Cited by 371Respiratory viral infections researchT-cell and B-cell ImmunologySARS-CoV-2 and COVID-19 Research

The CD8 T Cell Response to Respiratory Virus Infections

Open access
Schmidt, Megan E., Varga, Steven M.·2018·Frontiers in Immunology

Abstract

Humans are highly susceptible to infection with respiratory viruses including respiratory syncytial virus (RSV), influenza virus, human metapneumovirus, rhinovirus, coronavirus, and parainfluenza virus. While some viruses simply cause symptoms of the common cold, many respiratory viruses induce severe bronchiolitis, pneumonia, and even death following infection. Despite the immense clinical burden, the majority of the most common pulmonary viruses lack long-lasting efficacious vaccines. Nearly all current vaccination strategies are designed to elicit broadly neutralizing antibodies, which prevent severe disease following a subsequent infection. However, the mucosal antibody response to many respiratory viruses is not long-lasting and declines with age. CD8 T cells are critical for mediating clearance following many acute viral infections in the lung. In addition, memory CD8 T cells are capable of providing protection against secondary infections. Therefore, the combined induction of virus-specific CD8 T cells and antibodies may provide optimal protective immunity. Herein, we review the current literature on CD8 T cell responses induced by respiratory virus infections. Additionally, we explore how this knowledge could be utilized in the development of future vaccines against respiratory viruses, with a special emphasis on RSV vaccination.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2018.00678

Cites

142 of 142 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • It is likely that CD8+ T cells contribute to viral clearance in tissues.

    “Although the correlates of protection in this study were binding and neutralizing antibody titres34,35, it is likely that CD8+ T cells contribute to viral clearance in tissues36,37.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [102]Hussell T Pennycook A Openshaw PJ. Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology. Eur J Immunol (2001) 31(9): 2566– 73. 10.1002/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L 11536154 · DOI

Cited by

Sorted by citations

Authors
Schmidt, M. E., & Varga, S. M.
Affiliations
University of Iowa (US)
Corresponding author
Varga, Steven M.
Venue
Frontiers in Immunology
Published
2018-04-09
Volume
9
Pages
678-678
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2796489672
Cited by
371
References
142
Citations by year
2026: 24 · 2025: 31 · 2024: 29 · 2023: 62 · 2022: 56 · 2021: 84 · 2020: 61 · 2019: 19 · 2018: 5
FWCI
6.04
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Immunology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institutes of Health (R01AI124093, T32AI007485)
Topics
  • Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
CD8+ T cells, respiratory viruses, respiratory syncytial virus, influenza virus, human metapneumovirus, rhinovirus, coronavirus, parainfluenza virus, memory CD8+ T cells, mucosal immunity, vaccine development, RSV vaccination, age-related antibody decline
MeSH terms
Animals, Humans, Respiratory Tract Diseases, Virus Diseases, CD8-Positive T-Lymphocytes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review